Tredomo ^Company

Tredomo An integrated personal IOT medication monitoring and validation system for thermo-sensitive biologics Problem: - A diabetic on insulin is an example of patients and medications Tredomo impacts - These medications are called thermo-sensitive biologics, mostly pre-filled sharps - Once patient leaves healthcare facility with medication, Problems start, as both get disconnected from providers = Patient misses 50% of prescribed doses = biologics are dispensed in a regular bag with no preservation or monitoring = Stored at home fridge with doubtful preservation, no monitoring, insecure storage & contamination probability = Then disposed at home garbage bin with no monitoring, insecure storage & infection probability = All these issues aggregate to huge losses for individuals, corporates & governments involved with biologics ($100B) Solution: Tredomo is the solution that can solve all issues, improving millions of lives, and saving billions of dollars, through guaranteeing on-time delivery of valid & monitored thermo-sensitive dose, with smart disposal Replacing paper and plastic bag with a smart device, will create huge advantages - perfect environment for preserving medications, through temperature control and monitoring - In-unit disposal, for used sharps’ secured collection & Ultraviolet sterilization, to prevent infection - With rechargeable battery to be portable & interactive screen for notification - Each new dose & disposed sharp is monitored separately by sensors - Devices are Connected to AI-powered cloud application, for analytics, monitoring, notification, reporting & planning - Mobile App to connect & notify patient about dose schedules, alarms, directions & customer service Traction: Tredomo got a prepaid pilot from the number one selling pharmaceutical product globally and in history for $400,000 and another offer for $4,000,000, after amazing the 7th pharmaceutical company's CEO, and a 1,000 of it's high executives from allover the world, plus technical, legal and financial third parties, and Tredomo was just a prototype at that time Why Tredomo: - A one of a kind globally, irreplaceable by current solutions as singles, or even in collaborative without compromising all benefits Tredomo provides - Virgin, global, and huge market (TAM: $20B, SAM: $5B, SOM: $1B) - Scalability = Tredomo's first customer, Abbvie's "Humira" has 1.5M patient worldwide, other thermo-sensitive biologics are in tens of millions = All of biologics are expensive and with huge budget, thus pharmaceutical companies can afford Tredomo easily, same for insurance and government = A growing market as pharmaceutical industry is shifting from chemicals to biologics = Tredomo as a solution provides essential and game changing services for real unserved needs Fund deployment: - 30% Recruiting - 10% Development - 20% Operations - 10% Legal - 20% Regulatory - 10% marketing Plan Highlights - Hire full-time developers - Complete go to market version (V6) - Supply chain identification and security - Marketing and sales tour - Manufacturing, delivery and operation of closed deals Competitive Landscape - In-Unit Storage with Temperature control & Monitoring - In-Unit Smart Disposal with UV Sterilization for Sharps - Integrated Process form Prescription to Disposal Collection - AI-powered Cloud-Based Application & Proprietary Algorithms